Wed, Jan 28, 2026
Volume 4, Issue 1 And 2 (5-2017)
Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate
P. 13-18
S Hekmat 
, MM Aslani * , M Shafiee Ardestani , MR Aghasadeghi , SD Siadat , SM Sadat , M Mahdavi , S Shahbazi , F Asgarhalvaee , SMM Ghahari , F Tohidi
, MM Aslani * , M Shafiee Ardestani , MR Aghasadeghi , SD Siadat , SM Sadat , M Mahdavi , S Shahbazi , F Asgarhalvaee , SMM Ghahari , F Tohidi
Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections
P. 19-22
Design and construction of Beclin1-expressing plasmid as an autophagy inducing system: a novel strategy for enhancing the potency of DNA vaccines
P. 23-28
H Naziri , A Abdoli , A Tahmtan , F Motevalli , J Yavarian , M Khateri , MR Amiran , MR Aghasadeghi *
, A Abdoli , A Tahmtan , F Motevalli , J Yavarian , M Khateri , MR Amiran , MR Aghasadeghi *
Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate
P. 29-33
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails
P. 34-40
Immunization with cytomegalovirus gB protein produced by the Baculovirus Expression Vector System to elicit humoral immune response in BALB/c mice
P. 41-45
